MP
TLSI icon

MSD Partners’s TriSalus Life Sciences TLSI Stock Holding History

MSD Partners’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Hold
39,999
– – 0.19% 8
2025
Q4 		$279K Hold
39,999
– – 0.26% 7
2025
Q3 		$186K Hold
39,999
– – 0.12% 7
2025
Q2 		$218K Hold
39,999
– – 0.13% 7
2025
Q1 		$221K Hold
39,999
– – 0.16% 9
2024
Q4 		$200K Hold
39,999
– – 0.14% 9
2024
Q3 		$184K Buy
+39,999
New +$212K 0.12% 14
2022
Q4 		– Sell
-400,000
Closed -$3.97M – 80
2022
Q3 		$3.97M Hold
400,000
– – 0.32% 23
2022
Q2 		$3.94M Hold
400,000
– – 0.24% 31
2022
Q1 		$3.92M Buy
+400,000
New +$3.95M 0.21% 32

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

MSD Partners's TLSI Position: Q1 2026 in Review

MSD Partners held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 39,999 shares worth $160K. The position accounts for 0.19% of the portfolio, ranked #8.

MSD Partners first reported a position in TLSI in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.97M in Q3 2022. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • MSD Partners held 39,999 shares of TriSalus Life Sciences worth $160K as of Q1 2026.
  • MSD Partners left its TriSalus Life Sciences share count unchanged in Q1 2026.
  • TriSalus Life Sciences made up 0.19% of MSD Partners's portfolio in Q1 2026, its #8 holding.
  • MSD Partners first reported a position in TriSalus Life Sciences in Q1 2022 and has held it in 10 quarters since.
  • MSD Partners's TriSalus Life Sciences position peaked at $3.97M in Q3 2022.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on MSD Partners's 13F filing for Q1 2026, filed 15 May 2026.